OPEN END TURBO LONG - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME3HKX9

Real-time Bid/Ask 09:48:05 01/07/2024 pm IST
2.91 EUR / 2.94 EUR -4.41% Intraday chart for OPEN END TURBO LONG - BECTON DICKINSON AND CO.
Current month+3.38%
1 month+19.07%
Date Price Change
01/24/01 3.08 +0.65%
28/24/28 3.06 +4.44%
27/24/27 2.93 -3.30%
26/24/26 3.03 -6.48%
25/24/25 3.24 -4.14%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 06:15 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME3HKX
ISINDE000ME3HKX9
Date issued 13/11/2023
Strike 200.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.92
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.07
Lowest since issue 2.35
Spread 0.03
Spread %1.02%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.46%
Consensus